drugset / Trial / NCT02089295

Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions

NCT02089295

Phase 1 Completed 18 enrolled Pain Therapeutics
RandomizedCrossoverOpen-labelBasic science

Summary

To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 00345439 formulation under fed conditions in healthy volunteers.

Timeline

Start
2014-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 5 mg
Subject Oxycodone Other / unclassified 20 mg
Subject Oxycodone Other / unclassified 40 mg

Indications

No indication recorded.